Meridian Bioscience, Inc. (NASDAQ:VIVO)

CAPS Rating: 5 out of 5

A fully-integrated life science company whose principal businesses are development, manufacture, sale and distribution of diagnostic test kits; manufacture and distribution of bulk antigens and reagents; and manufacture of proteins and other biologicals.


Player Avatar pennysplants (99.54) Submitted: 11/22/2012 7:29:43 PM : Outperform Start Price: $20.34 VIVO Score: -48.14

CPHD vs VIVO? Reaffirming pending further DD. Cleaning up after 2 year hiatus from CAPS.

Featured Broker Partners